Revlis Biotech Company Limited. is committed to the innovative application and development in the digital health and medical field. With leading advantages in the combination of personal ECG technology and Artificial Intelligence, it has allowed us to be at the forefront of this growing industry
Cmate® End-to-End Solution
We provide an overall solution that includes smart terminal device/modules, SaaS service model and AI calculation engine. Its advantage lies in the modular architecture of software / hardware design, which can give partners more diversified and flexible applications, reduce entry barriers, and provide customized integrated development and sales services.
Globally Leading Cmate Multi-Dimensional AI Algorithm
We provide various health status indicators based on data and AI analysis, which can effectively help users improve the effectiveness of health management, and provide sustainable, high-accuracy, and low-burden premium health management solutions.
The high-precision physiological indicators
The 7 major physiological indicators can be accurately monitored:
Average Heart Rate & HRV
Heart Health Index
Blood Pressure Value
Blood Sugar Value